Hover a dot or row, or tab through the dots · bars scaled to the largest round ($196M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-542681
First filed2025-04-01
Latest2025-04-01
Sought$196M
Sold$196M
Investors23
Exemptions506(b)
Who backs Cognito Therapeutics Group, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-04-01
Related persons
Name
Relationship
Christian Howell
RelationshipExecutive Officer, Director
Gerald Chan
RelationshipDirector
Stephen Bruso
RelationshipDirector
Helen Liang
RelationshipDirector
Richard Kuntz
RelationshipDirector
Laura Brege
RelationshipDirector
Jarod Rutledge
RelationshipDirector
Facts
As its latest Form D states them
Industry
Other Health Care
State
Massachusetts (MA)
Exemptions
Rule 506(b)
First filed
2025-04-01
Latest filing
2025-04-01
Who backs Cognito Therapeutics Group, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)